Skip to content

S 8925 · New York · 2025-2026 · Billy

Skip to content

Home
/
Bills
/
New York
/
2025-2026
/
S 8925

New York · 2025-2026 session · senate

S 8925Prohibits the sale of 7-hydroxymitragynine products

Status: Passed chamber
Latest action: 2026-06-05 — PASSED ASSEMBLY
Primary sponsor: Christopher Ryan

Track this bill View changes+27 / −6 words · Medium

Sponsors

Christopher Ryan · primaryprimary
Jake Ashby (Republican/Conservative) · cosponsor
Patricia Fahy · cosponsor
Pete Harckham (Democratic/Working Families)

Public legislative record via Billy. Sign in to track, annotate, and export work product.

About public bill pages Compare Billy New York bill RSS

· cosponsor

Dean Murray (Republican/Conservative) · cosponsor

APAnthony H. Palumbo · cosponsor

Steve Rhoads (Republican/Conservative) · cosponsor

Versions

S8925—
S8925A—

Legislative history

Jun 5, 2026
PASSED ASSEMBLY
Jun 5, 2026
RETURNED TO SENATE
Jun 3, 2026
ORDERED TO THIRD READING RULES CAL.408
Jun 3, 2026
SUBSTITUTED FOR A9156B
Jun 2, 2026
PASSED SENATE
Jun 2, 2026
REFERRED TO WAYS AND MEANS
Jun 2, 2026
DELIVERED TO ASSEMBLY
May 26, 2026
ADVANCED TO THIRD READING
May 21, 2026
2ND REPORT CAL.
May 20, 2026
1ST REPORT CAL.1297
May 11, 2026
PRINT NUMBER 8925A
May 11, 2026
AMEND AND RECOMMIT TO CONSUMER PROTECTION
Jan 16, 2026
REFERRED TO CONSUMER PROTECTION

Official sources

Version 0PDF HTML
Version 1PDF

About this page

Is this the official New York bill page?: No — this is Billy’s public legislative record for S 8925. Official source links are listed above when publishers provide them.
Can I track updates?: Yes. Sign in to track S 8925, get alerts, annotate diffs, and export Word work product.